X0206 3 2019-08-08 0 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001785732 Stock Elyse C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to Buy) 10.82 2027-04-05 Common Shares 37000 D Employee Stock Option (Right to Buy) 37.54 2027-09-04 Common Shares 10000 D Employee Stock Option (Right to Buy) 20.79 2027-12-06 Common Shares 42612 D Employee Stock Option (Right to Buy) 32.42 2028-11-20 Common Shares 65000 D Employee Stock Option (Right to Buy) 50.85 2029-03-22 Common Shares 6000 D The option became exercisable as to 18,500 of these shares on and prior to April 6, 2019 and becomes exercisable as to the remaining 18,500 shares on April 6, 2020, subject to the reporting person's continued service as of such date. The option became exercisable as to 2,500 of these shares on September 5, 2018, with the remainder vesting in 3 equal installments on September 5, 2019, September 5, 2020 and September 5, 2021, subject to the reporting person's continuing service as of each applicable vesting date. The option became exercisable as to 10,653 of these shares on December 7, 2018, with the remainder vesting in 3 equal installments on December 7, 2019, December 7, 2020 and December 7, 2021, subject to the reporting person's continuing service as of each applicable vesting date. The option vests in 4 equal installments on the first, second, third and fourth anniversaries of November 20, 2018, in each case subject to the reporting person's continuing service as of each applicable vesting date. This option vested as to all 6,000 shares on June 27, 2019. Exhibit 24.1 - Power of Attorney /s/ James Engelhart, Attorney-in-fact 2019-08-19